24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Basic InformationLookupsLatest News
AHA News: Women May Be More Willing Than Men to Donate OrgansDNA Sensor Can Spot When COVID Is ContagiousTrials Show COVID Vaccines Well Worth It for Cancer PatientsCDC Endorses Booster Shots for Millions of AmericansChildhood Trauma Linked With Higher Odds for Adult Neurological IllsStudy Probes Relationship Between Migraines and SleepCancer in Hispanics: Good News and BadFDA Approves Pfizer Booster Shots for Seniors, High-Risk AmericansU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationAntibodies to Early Strains of COVID May Not Fight New Variants: StudyPregnant Women Who Get COVID Vaccine Pass Antibodies to NewbornsCDC Expert Panel to Weigh In on Vaccine BoostersWhich Kids Are at Highest Risk From COVID?4 Out of 10 Adults With No Known Heart Disease Have Fatty Hearts: StudyBooster Dose of J&J COVID Vaccine Increases ImmunityPost-Stroke Rehab: There's a Sweet Spot in the TimingCommon Form of Liver Cancer on the Rise in Rural AmericaCOVID Has Killed More Americans Than the Spanish Flu Did in 1918Telemedicine Gets High Marks for Follow-Ups After SurgeryPandemic Tied to Declining Birth Rates for U.S., Much of EuropeStudy Spots People at High Risk of Severe Breakthrough COVIDReview of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: FauciDelta Variant Now Fueling 99% of U.S. COVID CasesLower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company SaysFDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not YoungerLong-Haul COVID in Kids Typically Ends Within 3 Months: StudyPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotCommon Eye Conditions Tied to Higher Risk for DementiaDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyWHO Says Africa Will Get 30% of COVID Vaccines It Needs by FebruaryCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciEbola Vaccine Effective in African Clinical TrialBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsIsraeli Data on COVID Boosters to Be Published This Week in Major Journal
Questions and AnswersLinks
Related Topics


COVID Antibodies From Vaccination Are Almost 3 Times Higher Than From Infection

HealthDay News
by By Ernie Mundell and Robert Preidt HealthDay Reporters
Updated: Jul 15th 2021

new article illustration

THURSDAY, July 15, 2021 (HealthDay News) -- People who've been fully vaccinated against COVID-19 have a much stronger immune system response against the new coronavirus than those who've previously been infected, according to a new study.

"Vaccinated individuals had the highest antibody levels, nearly three times higher than that of convalescent individuals recovering from symptomatic COVID-19," an Israeli team reported.

What's more, while 99.4% of vaccinated people tested positive for COVID-fighting antibodies in blood samples just six days after their second dose of vaccine, the number of these "seropositive" people fell to just under 76% for people recovering from a COVID-19 infection.

These findings might encourage people who believe they're already well-protected because of a prior encounter with SARS-CoV-2 to go ahead and get vaccinated, one expert said.

"This is an encouraging study that further confirms that vaccination against COVID-19 provides a stronger immune response than recovering from infection," said COVID-19 expert Dr. Eric Cioe-Peña, who directs Global Health at Northwell Health, in New Hyde Park, N.Y. He wasn't involved in the new research.

The study also found that men and women have different antibody levels after either vaccination or infection.

"It's well-known that there are differences in immune response that vary with sex," noted virologist Dr. Amesh Adalja, who wasn't involved in the research.

"This is likely the result of differential proportions of hormones like estrogen and testosterone," said Adalja, a senior scholar at the Johns Hopkins Center for Health Security, in Baltimore.

The new research was led by Noam Shomron, head of the Computational Genomics Laboratory at Tel Aviv University, and Dr. Adina Bar Chaim, from the Shamir Medical Center in Tel Aviv. Their team assessed COVID-19 antibody levels in more than 26,000 blood samples from vaccinated and unvaccinated people, along with people who'd recovered from their COVID-19 infections.

The researchers also found age-related differences between convalescent or vaccinated men and women.

Among those older than 51, antibody levels were found to be higher in women than in men. This may be related to the change in levels of the female hormone estrogen, which occur around this age and affect the immune system, the study authors said.

In men, a rise in antibody levels was seen starting around 35, possibly associated with changes in levels of the male sex hormone testosterone and its effect on the immune system.

Overall, young adults had a higher level of antibodies that lasted longer compared to older vaccinated adults, the study found, and a decrease at a level of tens of percent occurred over time between younger and very old adults.

In young adults, a high concentration of antibodies is usually due to a strong immune response, while in older people it usually indicates overreaction of the immune system associated with severe illness, the researchers explained.

"Further research is required in order to obtain an in-depth understanding of the immune system's response to COVID-19, to recovery from the disease, and to the vaccine," the two lead authors wrote jointly in a Tel Aviv University news release.

The study was published on medRxiv, a "pre-print" server for health research, so it's important to note that the data have not yet been peer-reviewed.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.

SOURCES: Eric Cioe-Peña, MD, director of global health, Northwell Health, New Hyde Park, N.Y.; Amesh A. Adalja, MD, senior scholar, Johns Hopkins Center for Health Security, Baltimore; medRxiv, July 8, 2021, online; Tel Aviv University, news release, July 13, 2021